IL-38 limits alloreactivity through modulating myeloid and T cell activation
Anastasiia Kiprina, XU Wen-qing, Igor Mačinković, Nicola Martina Böffinger, Dmitry Namgaladze, Kristin Jordan, Mohammed A.F. Elewa, Anne‐Claire Jacomin, Ivan-Maximilano Kur, Blerina Aliraj, Katharina Imkeller, Bernhard Brüne, Andreas Weigert
This study shows IL-38 reduces monocyte antigen presentation and promotes regulatory T-cell expansion, thereby limiting alloreactivity in GvHD models.
bioRxiv · Jun 22, 2026 · PreprintImmunology